Colleen Kusy
Stock Analyst at Baird
(3.63)
Main Sectors:
Top Industries:
18 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OCUL Ocular Therapeutix | Maintains: Outperform | 17 24 | 11.41 | 110.34% | 5 | Oct 3, 2025 | |
CLYM Climb Bio | Initiates Coverage On: Outperform | 9 | 1.98 | 354.55% | 1 | Aug 15, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Outperform | 47 50 | 23.8 | 110.08% | 12 | Jul 18, 2025 | |
NUVL Nuvalent | Maintains: Outperform | 105 112 | 84.22 | 32.99% | 2 | Jun 25, 2025 | |
ELVN Enliven Therapeutics | Maintains: Outperform | 40 52 | 19.61 | 165.17% | 3 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 6 | 4.14 | 44.93% | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 41 | 17.57 | 133.35% | 4 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 6 | 1.64 | 265.85% | 5 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 65 | 15.89 | 309.06% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 100 75 | 8.28 | 805.8% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 27 25 | 11.56 | 116.26% | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 40 | n/a | n/a | 3 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 15 | n/a | n/a | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 255 210 | 6.38 | 3191.54% | 1 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 2.34 | 1352.99% | 5 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 230 | 2.05 | 11119.51% | 1 | Nov 2, 2021 |